Mpox: Canada, Nigeria Partner on Prevention

By Alabidun Shuaib AbdulRahman

The Nigerian Institute of Medical Research, NIMR, along with other institutions and stakeholders, has launched the Canada-Africa Mpox Partnership, CAMP, aimed at curbing the spread of Mpox and studying the dynamics of its transmission from humans to humans.

The project involves collaboration with the Canadian Institute of Health Research, CIHR, and the International Development Research Centre, IDRC.

The Nigeria consortium will work with their Canadian partners to inform the clinical and public health response to local and global epidemics of Mpox.

The project will involve community engagement and capacity building in three areas of focus, which are Mpox transmission, treatment, and vaccines.

It is said to have received ethical clearance to commence field operations from April for a 12-month period.

The stakeholders include researchers and communities, and the project aims to provide information for stakeholders to understand transmission dynamics and evaluate medical countermeasures of Mpox in Nigeria and Canada.

The project also seeks to co-develop regional capacity for responding to future infectious disease challenges.